Rokos Capital Management LLP Royalty Pharma PLC Transaction History

Rokos Capital Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $5.91 Million - $7.06 Million	-225,000 Reduced 16.89%	1,106,813 $30 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $6.66 Million - $8.23 Million	225,000 Added 20.33%	1,331,813 $40.9 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $20.1 Million - $24.2 Million	614,585 Added 124.86%	1,106,813 $39.9 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $18.5 Million - $21.8 Million	492,228 New	492,228 $20.6 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $12.1 Million - $14.1 Million	-333,778 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $13.3 Million - $15.6 Million	333,778 New	333,778 $13.7 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.